Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years old or older
- You have been diagnosed with liver cancer (HCC) that cannot be removed by surgery, either confirmed by a doctor's assessment or by a tissue sample
- You have received at least one dose of the drug combination Atezolizumab plus Bevacizumab and completed at least one round of a targeted radiation treatment called SIRT-Y90
- At least one medical visit has been recorded after starting both of these treatments
Who may not be able to join:
- You have been diagnosed with another type of cancer (other than a common skin cancer called basal cell carcinoma) either before or around the time you started the liver cancer treatments mentioned above
- You were already taking part in another interventional clinical study at or before the time you started treatment with Atezolizumab plus Bevacizumab or SIRT-Y90
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18234507085
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.